New formulation intravenous melphalan in the treatment of patients with metastatic renal cancer.
Falkson
C I
CI
Department of Medical Oncology, Faculty of Medicine, University of Pretoria, South Africa.
D000368:Aged; D015507:Drugs, Investigational / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007680:Kidney Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008558:Melphalan / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D009362:Neoplasm Metastasis
D015507:Drugs, Investigational; D008558:Melphalan